Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 74/100

Termination Rate

26.7%

4 terminated out of 15 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

7%

1 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed with results

Key Signals

4 with results67% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (1)
P 1 (1)
P 2 (6)
P 3 (1)

Trial Status

Completed8
Terminated4
Unknown2
Withdrawn1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT04958889CompletedPrimary

COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV

NCT04588363CompletedPrimary

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C

NCT04642638Phase 2Terminated

Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure

NCT05249816Phase 3CompletedPrimary

Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine

NCT04391309Phase 2Terminated

COVID-19 and Anti-CD14 Treatment Trial

NCT05545319Phase 2WithdrawnPrimary

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

NCT04933929Not ApplicableCompletedPrimary

Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization

NCT04725084CompletedPrimary

Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome

NCT04851821Phase 1Completed

The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)

NCT04940871Phase 2TerminatedPrimary

Study to Assess the Efficacy and Safety of Favipiravir-HU

NCT04611230CompletedPrimary

A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois

NCT04389840Phase 2Terminated

Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure

NCT04863547UnknownPrimary

Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection

NCT04768998UnknownPrimary

Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)

NCT04343261Phase 2CompletedPrimary

Convalescent Plasma in the Treatment of COVID 19

Showing all 15 trials

Research Network

Activity Timeline